Regulation of the fetal mouse ductus arteriosus is dependent on interaction of nitric oxide and COX enzymes in the ductal wall

Prostaglandins and Other Lipid Mediators

Volumn 88, Issue 3-4, 2009, Pages 89-96

  Reese, Jeff ^a,b   O'Mara, Patrick W ^a   Poole, Stanley D ^a   Brown, Naoko ^a   Tolentino, Chelsea ^a   Eckman, Delrae M ^c   Aschner, Judy L ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclooxygenase; Ductus arteriosus; Fetus; Nitric oxide; Prostaglandins

Indexed keywords

CYCLOOXYGENASE 2; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROSTAGLANDIN SYNTHASE; PROSTANOID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY TONE; ARTERY WALL; ARTICLE; CELL ISOLATION; DEVELOPMENTAL STAGE; DUCTUS ARTERIOSUS; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; FETUS; GESTATIONAL AGE; MOUSE; MYOGRAPHY; NONHUMAN; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PROTEIN PROTEIN INTERACTION; TERM BIRTH;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; CYCLOOXYGENASE INHIBITORS; DRUG INTERACTIONS; DUCTUS ARTERIOSUS; FEMALE; FETUS; INDOMETHACIN; MICE; MYOGRAPHY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; PREGNANCY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TIME FACTORS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 62849084086     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2008.11.001     Document Type: Article

References (49)

1. Cotton R.B., Stahlman M.T., Kovar I., and Catterton W.Z. Medical management of small preterm infants with symptomatic patent ductus arteriosus. J Pediatr 92 3 (1978) 467-473
2. Hammerman C. Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment. Clin Perinatol 22 2 (1995) 457-479
3. Smith G.C. The pharmacology of the ductus arteriosus. Pharmacol Rev 50 1 (1998) 35-58
4. Loftin C.D., Trivedi D.B., Tiano H.F., et al. Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. Proc Natl Acad Sci USA 98 3 (2001) 1059-1064
5. Nguyen M., Camenisch T., Snouwaert J.N., et al. The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature 390 6655 (1997) 78-81
6. Reese J., Anderson J.D., Brown N., Roman C., and Clyman R.I. Inhibition of cyclooxygenase isoforms in late- but not midgestation decreases contractility of the ductus arteriosus and prevents postnatal closure in mice. Am J Physiol Regul Integr Comp Physiol 291 6 (2006) R1717-R1723
7. Loftin C.D., Trivedi D.B., and Langenbach R. Cyclooxygenase-1-selective inhibition prolongs gestation in mice without adverse effects on the ductus arteriosus. J Clin Invest 110 4 (2002) 549-557
8. Reese J., Paria B.C., Brown N., Zhao X., Morrow J.D., and Dey S.K. Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse. Proc Natl Acad Sci USA 97 17 (2000) 9759-9764
9. Baragatti B., Brizzi F., Ackerley C., Barogi S., Ballou L.R., and Coceani F. Cyclooxygenase-1 and cyclooxygenase-2 in the mouse ductus arteriosus: individual activity and functional coupling with nitric oxide synthase. Br J Pharmacol 139 8 (2003) 1505-1515
10. Trivedi D.B., Sugimoto Y., and Loftin C.D. Attenuated cyclooxygenase-2 expression contributes to patent ductus arteriosus in preterm mice. Pediatr Res 60 6 (2006) 669-674
11. Momma K., and Toyono M. The role of nitric oxide in dilating the fetal ductus arteriosus in rats. Pediatr Res 46 3 (1999) 311-315
12. Richard C., Gao J., LaFleur B., et al. Patency of the preterm fetal ductus arteriosus is regulated by endothelial nitric oxide synthase and is independent of vasa vasorum in the mouse. Am J Physiol Regul Integr Comp Physiol 287 3 (2004) R652-R660
13. Takizawa T., Kihara T., and Kamata A. Increased constriction of the ductus arteriosus with combined administration of indomethacin and l-NAME in fetal rats. Biol Neonate 80 1 (2001) 64-67
14. Baragatti B., Brizzi F., Barogi S., et al. Interactions between NO, CO and an endothelium-derived hyperpolarizing factor (EDHF) in maintaining patency of the ductus arteriosus in the mouse. Br J Pharmacol 151 1 (2007) 54-62
15. Ishii T., Kuwaki T., Masuda Y., and Fukuda Y. Postnatal development of blood pressure and baroreflex in mice. Auton Neurosci 94 1-2 (2001) 34-41
16. Kuwaki T., Ishii T., Ju K., Yanagisawa M., and Fukuda Y. Blood pressure of endothelin-3 null (-/-) knockout mice and endothelin A receptor null (-/-) knockout mice under anaesthesia. Clin Sci (Lond) 103 Suppl. 48 (2002) 48S-52S
17. Huang Y., Guo X., and Kassab G.S. Axial nonuniformity of geometric and mechanical properties of mouse aorta is increased during postnatal growth. Am J Physiol Heart Circ Physiol 290 2 (2006) H657-H664
18. Ishiwata T., Nakazawa M., Pu W.T., Tevosian S.G., and Izumo S. Developmental changes in ventricular diastolic function correlate with changes in ventricular myoarchitecture in normal mouse embryos. Circ Res 93 9 (2003) 857-865
19. Tada T., and Kishimoto H. Ultrastructural and histological studies on closure of the mouse ductus arteriosus. Acta Anat (Basel) 139 4 (1990) 326-334
20. Chorne N., Jegatheesan P., Lin E., Shi R., and Clyman R.I. Risk factors for persistent ductus arteriosus patency during indomethacin treatment. J Pediatr 151 6 (2007) 629-634
21. Koch J., Hensley G., Roy L., Brown S., Ramaciotti C., and Rosenfeld C.R. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 117 4 (2006) 1113-1121
22. Coceani F., Liu Y., Seidlitz E., et al. Endothelin A receptor is necessary for O(2) constriction but not closure of ductus arteriosus. Am J Physiol 277 4 Pt 2 (1999) H1521-H1531
23. Agren P., Cogolludo A.L., Kessels C.G., et al. Ontogeny of chicken ductus arteriosus response to oxygen and vasoconstrictors. Am J Physiol Regul Integr Comp Physiol 292 1 (2007) R485-R496
24. Kajino H., Chen Y.Q., Chemtob S., Waleh N., Koch C.J., and Clyman R.I. Tissue hypoxia inhibits prostaglandin and nitric oxide production and prevents ductus arteriosus reopening. Am J Physiol Regul Integr Comp Physiol 279 1 (2000) R278-R286
25. Smith G.C., and McGrath J.C. Characterisation of the effect of oxygen tension on response of fetal rabbit ductus arteriosus to vasodilators. Cardiovasc Res 27 12 (1993) 2205-2211
26. Clyman R.I. Ductus arteriosus: current theories of prenatal and postnatal regulation. Semin Perinatol 11 1 (1987) 64-71
27. Clyman R.I., Mauray F., Demers L.M., Rudolph A.M., and Roman C. Does oxygen regulate prostaglandin-induced relaxation in the lamb ductus arteriosus?. Prostaglandins 19 3 (1980) 489-498
28. Coceani F., Huhtanen D., Hamilton N.C., Bishai I., and Olley P.M. Involvement of intramural prostaglandin E2 in prenatal patency of the lamb ductus arteriosus. Can J Physiol Pharmacol 64 6 (1986) 737-744
29. Rabinovitch M., Boudreau N., Vella G., Coceani F., and Olley P.M. Oxygen-related prostaglandin synthesis in ductus arteriosus and other vascular cells. Pediatr Res 26 4 (1989) 330-335
30. Thebaud B., Michelakis E.D., Wu X.C., et al. Oxygen-sensitive Kv channel gene transfer confers oxygen responsiveness to preterm rabbit and remodeled human ductus arteriosus: implications for infants with patent ductus arteriosus. Circulation 110 11 (2004) 1372-1379
31. Kajino H., Taniguchi T., Fujieda K., Ushikubi F., and Muramatsu I. An EP4 receptor agonist prevents indomethacin-induced closure of rat ductus arteriosus in vivo. Pediatr Res 56 4 (2004) 586-590
32. Friedman W.F., Printz M.P., Kirkpatrick S.E., and Hoskins E.J. The vasoactivity of the fetal lamb ductus arteriosus studied in utero. Pediatr Res 17 5 (1983) 331-337
33. Sodini D., Baragatti B., Barogi S., Laubach V.E., and Coceani F. Indomethacin promotes nitric oxide function in the ductus arteriosus in the mouse. Br J Pharmacol 153 8 (2008) 1631-1640
34. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., and Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90 15 (1993) 7240-7244
35. Cuzzocrea S., and Salvemini D. Molecular mechanisms involved in the reciprocal regulation of cyclooxygenase and nitric oxide synthase enzymes. Kidney Int 71 4 (2007) 290-297
36. Mollace V., Muscoli C., Masini E., Cuzzocrea S., and Salvemini D. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 57 2 (2005) 217-252
37. Davidge S.T., Baker P.N., Laughlin M.K., and Roberts J.M. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res 77 2 (1995) 274-283
38. Pilane C.M., and Labelle E.F. Nitric oxide stimulated vascular smooth muscle cells undergo apoptosis induced in part by arachidonic acid derived eicosanoids. J Cell Physiol 204 2 (2005) 423-427
39. Hardy P., Abran D., Hou X., et al. A major role for prostacyclin in nitric oxide-induced ocular vasorelaxation in the piglet. Circ Res 83 7 (1998) 721-729
40. Zenge J.P., Rairigh R.L., Grover T.R., et al. NO and prostaglandin interactions during hemodynamic stress in the fetal ovine pulmonary circulation. Am J Physiol Lung Cell Mol Physiol 281 5 (2001) L1157-L1163
41. Bakker E.N., and Sipkema P. Permissive effect of nitric oxide in arachidonic acid induced dilation in isolated rat arterioles. Cardiovasc Res 38 3 (1998) 782-787
42. Kim S.F., Huri D.A., and Snyder S.H. Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 310 5756 (2005) 1966-1970
43. Xu L., Han C., Lim K., and Wu T. Activation of cytosolic phospholipase A2{alpha} through nitric oxide-induced S-nitrosylation: involvement of inducible nitric-oxide synthase and cyclooxygenase-2. J Biol Chem 283 6 (2008) 3077-3087
44. Perkins D.J., and Kniss D.A. Blockade of nitric oxide formation down-regulates cyclooxygenase-2 and decreases PGE2 biosynthesis in macrophages. J Leukoc Biol 65 6 (1999) 792-799
45. Hughes F.J., Buttery L.D., Hukkanen M.V., O'Donnell A., Maclouf J., and Polak J.M. Cytokine-induced prostaglandin E2 synthesis and cyclooxygenase-2 activity are regulated both by a nitric oxide-dependent and -independent mechanism in rat osteoblasts in vitro. J Biol Chem 274 3 (1999) 1776-1782
46. Park S.W., Lee S.G., Song S.H., et al. The effect of nitric oxide on cyclooxygenase-2 (COX-2) overexpression in head and neck cancer cell lines. Int J Cancer 107 5 (2003) 729-738
47. Pelligrino D.A., and Wang Q. Cyclic nucleotide crosstalk and the regulation of cerebral vasodilation. Prog Neurobiol 56 1 (1998) 1-18
48. da Cunha V., Rossoni L.V., Oliveira P.A., et al. Cyclooxygenase inhibition reduces blood pressure elevation and vascular reactivity dysfunction caused by inhibition of nitric oxide synthase in rats. Clin Exp Hypertens 22 2 (2000) 203-215
49. Laemmel E., Bonnardel-Phu E., Hou X., Seror J., and Vicaut E. Interaction between nitric oxide and prostanoids in arterioles of rat cremaster muscle in vivo. Am J Physiol Heart Circ Physiol 285 3 (2003) H1254-H1260